11 Years Later, Gene Therapy Still Effective in HIV Patients (2 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

11 Years Later, Gene Therapy Still Effective in HIV Patients (2 of 3)

Caption

A laboratory technician works in Penn Medicine's Clinical Cell and Vaccine Production Facility, where the modified T cells are manufactured. This image relates to a paper that appeared in the May 2, 2012 issue of Science Translational Medicine, published by AAAS. The paper, by Dr. J. Scholler at the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pa., and colleagues, was titled, "Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells."

Credit

Image courtesy of Penn Medicine

Usage Restrictions

Please cite the owner of the image when publishing. This image may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.